These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 9010267)

  • 21. High immunoreactivity of lactoferrin contaminating commercially purified myeloperoxidase.
    Audrain MA; Baranger TA; Lockwood CM; Esnault VL
    J Immunol Methods; 1994 Nov; 176(1):23-31. PubMed ID: 7963592
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Anti-idiotype antibodies to anti-myeloperoxidase autoantibodies in patients with systemic vasculitis.
    Jayne DR; Esnault VL; Lockwood CM
    J Autoimmun; 1993 Apr; 6(2):221-6. PubMed ID: 8388692
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Epitope analysis of myeloperoxidase (MPO) specific anti-neutrophil cytoplasmic autoantibodies (ANCA) in MPO-ANCA-associated glomerulonephritis.
    Fujii A; Tomizawa K; Arimura Y; Nagasawa T; Ohashi YY; Hiyama T; Mizuno S; Suzuki K
    Clin Nephrol; 2000 Apr; 53(4):242-52. PubMed ID: 10809410
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinical features of patients with anti-neutrophil cytoplasmic autoantibodies targeting native myeloperoxidase antigen.
    Yamanishi Y; Ito-Ihara T; Nagao T; Uno K; Kobayashi S; Muso E; Shane PY; Firestein GS; Hashimoto H; Okazaki T; Suzuki K
    Mod Rheumatol; 2013 Sep; 23(5):963-71. PubMed ID: 23085883
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Autoantibodies to myeloperoxidase in brown Norway rats treated with mercuric chloride.
    Esnault VL; Mathieson PW; Thiru S; Oliveira DB; Martin-Lockwood C
    Lab Invest; 1992 Jul; 67(1):114-20. PubMed ID: 1320710
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Anti-neutrophil cytoplasmic autoantibody pathogenicity revisited: pathogenic versus non-pathogenic anti-neutrophil cytoplasmic autoantibody.
    Land J; Rutgers A; Kallenberg CG
    Nephrol Dial Transplant; 2014 Apr; 29(4):739-45. PubMed ID: 24398891
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Myeloperoxidase autoantibodies distinguish vasculitis mediated by anti-neutrophil cytoplasm antibodies from immune complex disease in MRL/Mp-lpr/lpr mice: a spontaneous model for human microscopic angiitis.
    Harper JM; Thiru S; Lockwood CM; Cooke A
    Eur J Immunol; 1998 Jul; 28(7):2217-26. PubMed ID: 9692891
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Factors involved in the pathogenesis of neutrophilic vasculitis in MRL/Mp-lpr/lpr mice: a model for human microscopic angiitis.
    Harper JM; Healey DG; Thiru S; Gordon C; Cook A
    Autoimmunity; 1999 Oct; 31(2):133-45. PubMed ID: 10680752
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Two types of myeloperoxidase-antineutrophil cytoplasmic autoantibodies with a high affinity and a low affinity in small vessel vasculitis.
    Yoshida M; Sasaki M; Nakabayashi I; Akashi M; Tomiyasu T; Yoshikawa N; Kojima T; Ohno N; Yamada M
    Clin Exp Rheumatol; 2009; 27(1 Suppl 52):S28-32. PubMed ID: 19646343
    [TBL] [Abstract][Full Text] [Related]  

  • 30. An IgM class anti-neutrophil cytoplasm antibody inhibits neutrophil adhesion and apoptosis via a Syk dependent signaling cascade.
    Hayes MJ; Cambridge G
    Mol Immunol; 2004 Jun; 41(4):457-68. PubMed ID: 15163542
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Exclusion of two major areas on thyroid peroxidase from the immunodominant region containing the conformational epitopes recognized by human autoantibodies.
    Nishikawa T; Rapoport B; McLachlan SM
    J Clin Endocrinol Metab; 1994 Dec; 79(6):1648-54. PubMed ID: 7527407
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinical spectrum associated with ANCA of defined antigen specificities in 98 selected patients.
    Geffriaud-Ricouard C; Noël LH; Chauveau D; Houhou S; Grünfeld JP; Lesavre P
    Clin Nephrol; 1993 Mar; 39(3):125-36. PubMed ID: 7681736
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Use of antineutrophil cytoplasmic autoantibodies in diagnosing vasculitis in a Chinese patient population.
    Li PK; Leung JC; Lai FM; Wang A; Lui SF; Leung CB; Lai KN
    Am J Nephrol; 1994; 14(2):99-105. PubMed ID: 7915885
    [TBL] [Abstract][Full Text] [Related]  

  • 34. B cell epitope specificity in ANCA-associated vasculitis: does it matter?
    van der Geld YM; Stegeman CA; Kallenberg CG
    Clin Exp Immunol; 2004 Sep; 137(3):451-9. PubMed ID: 15320893
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Studies of epitope restriction on myeloperoxidase (MPO), an important antigen in systemic vasculitis.
    Short AK; Lockwood CM
    Clin Exp Immunol; 1997 Nov; 110(2):270-6. PubMed ID: 9367412
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Epitope mapping of myeloperoxidase antibodies in propylthiouracil-induced vasculitis and microscopic polyangiitis].
    Ye H; Guo XH; Zhao MH; Gao Y; Zhang Y; Gao Y
    Zhonghua Nei Ke Za Zhi; 2004 Dec; 43(12):915-9. PubMed ID: 15730737
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Autoantibodies developing to myeloperoxidase and proteinase 3 in systemic vasculitis stimulate neutrophil cytotoxicity toward cultured endothelial cells.
    Savage CO; Pottinger BE; Gaskin G; Pusey CD; Pearson JD
    Am J Pathol; 1992 Aug; 141(2):335-42. PubMed ID: 1323218
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Involvement of pentraxin-3 in anti-neutrophil cytoplasmic antibody production induced by aluminum salt adjuvant.
    Nagai K; Aratani Y; Shibuya A; Yamagata K
    Clin Exp Rheumatol; 2017; 35(5):735-738. PubMed ID: 28850023
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [A preliminary study of the significance of autoantibodies against light chain of myeloperoxidase on pulmonary damages in myeloperoxidase-antineutrophil cytoplasmic antibody associated vasculitis].
    Zhang L; Shuai Z; Hu Z; Zhang M; Chen S
    Zhonghua Nei Ke Za Zhi; 2015 Jun; 54(6):511-6. PubMed ID: 26359012
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Epitope analysis of insulin autoantibodies using recombinant Fab.
    Padoa CJ; Crowther NJ; Thomas JW; Hall TR; Bekris LM; Torn C; Landin-Olsson M; Ortqvist E; Palmer JP; Lernmark A; Hampe CS
    Clin Exp Immunol; 2005 Jun; 140(3):564-71. PubMed ID: 15932520
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.